Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine
Irene V. Bijnsdorp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Godefridus J. Peters(Gdańsk Medical University), Reto A. Schwendener(University of Zurich), Kees Smid(Vrije Universiteit Amsterdam), Nienke Losekoot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Iduna Fichtner(Max Delbrück Center), Herbert Schott(University of Tübingen), Sarah Schott(Leibniz University Hannover), Adrie C. Laan(Amsterdam UMC Location Vrije Universiteit Amsterdam), Richard J. Honeywell(Amsterdam University Medical Centers)
Cited by 12
Related Papers
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes
|Cell Reports|2014|592
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
|European Journal of Cancer and Clinical Oncology|1991|460
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430